Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  

| More

India Strategy & Q4FY22 Review - Long term growth prospects to overshadow near term uncertainties

Posted On: 2022-06-11 13:55:47 (Time Zone: IST)

By Mr. Amnish Aggarwal - Director - Research at Prabhudas Lilladher.

Global Headwinds Just a Blip in India growth story: Global headwinds emanating from geo political uncertainty, disruption of supply chain, rising crude and commodity prices and global food shortage has led to aggressive increase in interest rates by central banks. We note that the rate tightening cycle is far from being over with further increase of 50-100bps in India in next 3-6 months. We believe further increase in crude prices and shortage of key components is slowly pushing major economies towards recession. We believe that India is in a unique position given 1) Huge domestic demand 2) self sufficiency in major food items 3) Govt support to develop Infra 4) strong corporate balance sheets and 5) emerging domestic investor class which has enabled absorb FII selling from past 3 quarters. We believe India will continue to remain as a major growth engine and current geopolitical impasse will only increase opportunities in both domestic market and also in global markets. We believe this uncertainty is only a passing phase and add fundamentally strong companies with business moats in uncertain times.

- 4Q22 has seen sales, EBIDTA and PBT lower than estimates by 0.8%, 1.9% and 6.9% respectively. 4Q was impacted due to 3rd wave of covid, although the impact was much less than 2nd wave of covid. Recovery post 3rd wave was quick although it got impacted by Russia Ukraine war from end of February, which disrupted supply chains and led to jump in commodity and crude prices. Demand remained impacted for Consumer staples, 2W, cement, Durables etc. LCV, Capital Goods, Multiplexes, Apparels and travel showed smart increase on a low base. Rural slowdown sustained amidst poor sentiment and high inflation.

- Maximum beat from estimates was recorded in Agri Chemicals, Chemicals, Auto and HFC

- Major Rating Upgrade: Avenue Supermart, Jubilant Foods, Hindalco, JK Lakshmi, Aarti Inds, LIC Housing and Chola.

- Rating Downgrade: Ambuja Cement, Bayer, Avaas Housing, LTTS, HCL, Tata Steel, JSPL, JSW Steel, IOC and Lupin

- Major Estimates Upgrade - M&M, SBI, Chola, Ambuja cement, Fine Org, and IOC

- Estimate Downgrade - HDFC, HDFC Bank, Muthoot, Ramco Cement, Kansai, Apollo Hospital, NH, Infy, Wipro, Zeel, Tata Steel, JSPL, JSW, SAIL, GAIL, IOC, Aurobindo and Lupin. Downgrades outweigh upgrades by 2.25:1

- NIFTY EEPS is estimated at 14.7% EPS CAGR over FY22-24 with FY23/24 EPS of Rs773.6 and 891. Our estimates are lower than consensus by 2.2/1.2% for FY23/24. NIFTY is currently trading at 20.7x 1-year forward EPS which is at 1% discount to 10 year average of 20.9x.

- Base Case: we value NIFTY at 10 year av. PE (20.7x) with March 24 EPS of 891 and arrive at June 23 target of 18622 (18470 based on 20.8xMarch 24 EPS earlier), a 13% upside.

- Bull Case, we value NIFTY at 10% premium to 10 year average (23x) and arrive at bull case target of 20484 (20317 earlier).

- Bear Case like March20 can see Nifty trading at 20% discount to LPA with a target of 14898. However we remain positive on India growth given strong tailwinds and expect positive returns by end of FY23.

- Model Portfolio - We remain overweight on Auto, Banks, IT services and Healthcare. We remain Underweight on Metals, Cement, Consumer, Oil and Gas and NBFC and increase cash to 3%. Our Model portfolio has outperformed NIFTY by 717bps since inception and 44bps in last 2 months.

- High Conviction Picks - We remove HDFC Bank, JSPL and Fortis Hospitals while we and add ICICI Bank and Apollo Hospitals.

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Gladiator Stocks - Minda Industries - ICICI Direct

Reliance Industries - Company Update - In fine fettle amidst global uncertainty - BUY

Sector Update - Sugar - ICICI Direct

Initiating Coverage - Hindustan Aeronautics Ltd - ICICI Direct

Rallis India - Company Update - Margin pressure likely to persist in near term..!! - Upgrade to 'BUY'

Indoco Remedies - Q4FY22 Result Update - In-line quarter; strong revenue guidance for US & EU mkt - Upgrade to 'BUY'

Indraprastha Gas - Q4FY22 Result Update - Impressive performance - BUY

KEC International - Annual Report Analysis - Healthy outlook across business segment - Accumulate

Westlife Development - Q4FY22 Result Update - Approaching the tipping point; Buy for LT Gains

Reliance Research downgrades Bajaj Auto to Sell

NOCIL - Q4FY22 Result Update - Strong operating performance amidst challenges - BUY

Gujarat Gas - Company Update - Deftly negotiating through tough times - BUY

Orient Electric - Gaining market share via innovation: initiate with ADD - ICICI Securities

Manappuram Finance - Q4FY22 Result Update - Intense Competition Put Pressure on Yields - BUY

Derivatives Weekly View - June 24, 2022 - ICICI Direct

Stock Tales - Newgen Software - ICICI Direct

Weekly Report - June 25, 2022 - Mr. Mitul Shah - Head of Research at Reliance securities

Gladiator Stocks - Bosch - ICICI Direct

Management Meet Update - Sheela Foam - ICICI Direct

Gladiator Stocks - Mahindra & Mahindra - ICICI Direct

Banks - Modifications to PPI and its impact on cards - Negligible impact, if any, for stocks under coverage

LIC Housing Finance - Q4FY22 Result Update - Fixed rate liabilities could cushion NIM - BUY

Navneet Education - Q4FY22 Result Update - Growth levers in place - BUY

MPC Minutes: Jun-22: All eyes on inflation - Acuité Ratings

Nazara Technologies - Management Meet Update - Breaking through the ESports landscape - BUY

Sector update - Quick Service Restaurants - YES Securities

JK Lakshmi Cement - Q4FY22 Result Update - Strong performance; Valuations drive upgrade - Accumulate

Would it be wise to invest in a home early in your career?

Dr. Reddy's Laboratories - Analyst Meet Update - Multiple growth initiatives - BUY

Dhanuka Agritech - Management Meet Update - 1Q likely to be subdued; all hopes pinned on the monsoons - BUY

BUY Ipca Laboratories - Q4FY22 Result Update - Weak exports; gradual recovery

Acuité expects India's current account deficit to widen to more than USD 90 bn in FY23 - Acuité Macro Pulse

Inflationary concerns will continue to weigh on the pace of economic revival in FY23 - Acuité Macroeconomic Performance index

City Union Bank - Q4FY22 Result Update - Asset quality on the mend - BUY

Banks - BNPL - Early results are not that exciting as yet - Kotak

Acuité expects FY23 GDP growth estimate at 7.5% - Acuité Macro Pulse - Growth - May-22 Edition

Base factor pushes up IIP in Apr-22 to an 8-month high - Acuité Ratings

India Equity Strategy - Quarterly flipbook: Q4FY22-Cost inflation driving downgrades

FMCG - D2C is here to stay; omni-channel the way forward - HDFC Securities

Automobile Sector - Monthly Quick View - May'22 - Steady Performance Improvement, backed by Gradual Rural Recovery

BFSI - New normal rate cycle; brace for transmission effects - HDFC Securities

SBI Cards and Payment Services - BUY - TP Rs. 1260 - YES SECURITIES

RBI frontloads rate hike amid increased inflationary headwinds - Acuité Ratings

Monetary Policy June 2022 - Axis MF Views

RBI Monetary Policy View - Mr. Dhiraj Relli, MD & CEO, HDFC Securities

Monetary Policy - entering the red zone - Anuj Puri, ANAROCK

Mr. Murali Ramakrishnan, MD &CEO, South Indian Bank on RBI Monetary Policy

Comments on RBI's MPC Policy Jun'22 - Acuité Ratings

Views on RBI Monetary Policy - June 2022

Bayer Cropscience - Q4FY22 Result Update - Healthy all round performance - BUY

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020